Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 24

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

541

HTML

4764

Figures (1-1)

275

Tables (1-2)

234

Sum=5814

Jun 28, 2007 (publication date) through Feb 24, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jun 28, 2007; 13(24): 3359-3363
Published online Jun 28, 2007. doi: 10.3748/wjg.v13.i24.3359

Table 1 Baseline characteristics of the patients

	Patient 1	Patient 2	Patient 3	Patient 4
Age (yr)	40	53	45	53
Gender	Male	Female	Male	Female
Etiology of cirrhosis	Hepatitis B	PBC	Cryptogenic	AIH
Medications	Lamivudine, Spironolactone, Furosmide	UDCA, Spironolactone, Furosmide	Spironolactone, Furosmide	Spironolactone, Furosmide

UDCA: Ursodeoxy-cholic acid; AIH: Autoimmune hepatitis; PBC: Primary biliary cirrhosis.

Citation: Mohamadnejad M, Namiri M, Bagheri M, Hashemi SM, Ghanaati H, Zare Mehrjardi N, Kazemi Ashtiani S, Malekzadeh R, Baharvand H. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol 2007; 13(24): 3359-3363
URL: https://www.wjgnet.com/1007-9327/full/v13/i24/3359.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i24.3359